Qualitative and quantitative studies on chemical constituents of Ling-gui-zhu-gan decoction: In vitro and in vivo

被引:2
|
作者
Li, Siyue [1 ]
Gao, Yutong [1 ]
Wang, Xue [1 ]
Wang, Zhe [1 ]
Li, Nan [1 ]
Shang, Yonglin [1 ]
Han, Fei [1 ]
Yu, Jia [1 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharm, 103 Wenhua Rd, Shenyang 110016, Peoples R China
基金
中国国家自然科学基金;
关键词
chemical constituents; Fourier transform ion cyclotron resonance mass spectrometry; identification; Ling-gui-zhu-gan decoction; metabolite; LIQUID-CHROMATOGRAPHY; LINGGUIZHUGAN DECOCTION; MASS-SPECTROMETRY; IDENTIFICATION; METABOLISM; STRATEGY; PLASMA;
D O I
10.1002/jssc.202300465
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Ling-gui-zhu-gan decoction has significant therapeutic effects in the treatment of diseases related to phlegm and fluid retention. In this study, we aimed to qualitatively characterize the chemical constituents of Ling-gui-zhu-gan decoction in vitro and in vivo by HPLC coupled to Fourier transform ion cyclotron resonance MS, and quantitively determine the contents of typical chemical constituents by HPLC method. As a result, a total of 75 chemical constituents were discovered including 37 flavonoids and their glycosides, 20 saponins, 9 sterols, 3 organic acids and their derivatives, 3 lactones, 2 coumarins, and 1 alcohol. Among them, 17 chemical constituents were specifically identified. Subsequently, an HPLC method was established for simultaneous determination of seven chemical constituents. Finally, a total of 40 prototype components were initially detected by HPLC-MS method in the biological samples of rats after their water extract was orally administrated. Among them, 29, 27, 12, and 32 prototype components were detected in plasma, bile, urine, and feces, respectively. Moreover, 34 metabolites, including 16 phase II metabolites, were detected for the first time. In conclusion, this study lays the foundation for the identification of chemical components in vitro and in vivo and the elucidation of the potential pharmacodynamic components of Ling-gui-zhu-gan decoction.
引用
收藏
页数:19
相关论文
共 34 条
  • [21] LC-ESI-MS/MS method for simultaneous determination of eleven bioactive compounds in rat plasma after oral administration of Ling-Gui-Zhu-Gan Decoction and its application to a pharmacokinetics study
    Ji, Bin
    Zhao, Yunli
    Yu, Peipei
    Yang, Bin
    Zhou, Ceng
    Yu, Zhiguo
    TALANTA, 2018, 190 : 450 - 459
  • [22] Spectrum-effect relationship analysis based on HPLC-FT-ICR-MS and multivariate statistical analysis to reveal the pharmacodynamic substances of Ling-Gui-Zhu-Gan decoction on Alzheimer's disease
    Li, Siyue
    Sun, Yuanfang
    Gao, Yutong
    Yu, Xinying
    Zhao, Chun
    Song, Xiuping
    Han, Fei
    Yu, Jia
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2024, 237
  • [23] The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules
    Yanqi Dang
    Shijun Hao
    Wenjun Zhou
    Li Zhang
    Guang Ji
    BMC Complementary and Alternative Medicine, 19
  • [24] Exploration of the possible mechanisms of Ling Gui Zhu Gan decoction in nephrotic syndrome based on network pharmacology, molecular docking and molecular dynamics simulation
    Shi, Li
    Deng, Yuanjun
    Luo, Denggui
    Li, Lei
    Kuang, Xuyi
    Qi, Airong
    Fu, Bo
    MEDICINE, 2023, 102 (29) : E34446
  • [25] Pharmacokinetic evaluation of 24 representative components of Ling-Gui-Zhu-Gan decoction in acute myocardial infarction model rats via a validated ultrahigh-performance liquid chromatography-tandem mass spectrometry method
    Li, Jing
    Ge, Ruirui
    Wang, Feng
    Gu, Jinfan
    Zuo, Mengyu
    Tang, Tongjuan
    Ge, Xinru
    Niu, Yingchao
    Wang, Liang
    Huang, Jinling
    Chen, Jian
    RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2023, 37 (19)
  • [26] Ling Gui Zhu Gan varied decoction attenuates acute myocardial infarction of mice via inhibiting inflammatory response and regulating gut microbiota
    Liu, Xiaoyu
    Wang, Chengbin
    Zhang, Wei
    Wu, Haibo
    Shi, Yuanyuan
    MINERVA SURGERY, 2024, 79 (04): : 496 - 498
  • [27] Ling-Gui-Zhu-Gan Decoction Alleviates Cognitive Deficits in Alzheimer's Disease by Activating the Nuclear Factor-Erythroid Factor 2-Related Factor 2/The Antioxidant Responsive Element Signaling Pathway
    Zhang, Jingyuan
    Yang, Dongqing
    Zhao, Juan
    Ling, Yun
    Zhou, Chunxiang
    CURRENT TOPICS IN NUTRACEUTICAL RESEARCH, 2023, 21 (01) : 1 - 9
  • [28] Comparison of pharmacokinetic profiles of seven major bioactive components in normal and non-alcoholic fatty liver disease (NAFLD) rats after oral administration of Ling-Gui-Zhu-Gan decoction by UPLC-MS/MS
    Nie, Wenlong
    Yang, Yang
    Li, Ling
    Ding, Yue
    Chen, Xingmi
    Li, Ming
    He, Ning
    Ji, Guang
    Zhang, Yong
    Kang, Ping
    Zhang, Tong
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [29] Ling-gui-zhu-gan promotes adipocytes browning via targeting the miR-27b/PRDM16 pathway in 3T3-L1 cells
    Ye, Zimengwei
    Zhao, Yi
    Cui, Yanjing
    Xu, Bingrui
    Wang, Fan
    Zhao, Dandan
    Dong, Guangtong
    Wang, Zhufeng
    Wu, Rui
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [30] Ling-Gui-Zhu-Gan Decoction Protects H9c2 Cells against H2O2-Induced Oxidative Injury via Regulation of the Nrf2/Keap1/HO-1 Signaling Pathway
    Wang, Xiang
    Tang, Tongjuan
    Zhai, Mengting
    Ge, Ruirui
    Wang, Liang
    Huang, Jinling
    Zhou, Peng
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020